Longitudinal Estimation of the Clinically Significant Change in the Treatment of Major Depression Disorder

Frontiers in Psychology - Switzerland
doi 10.3389/fpsyg.2018.01406
Full Text
Abstract

Available in full text

Categories
Psychology
Date
Authors
Publisher

Frontiers Media SA

Related search

Duloxetine in the Treatment of Major Depressive Disorder

Journal of Clinical Psychiatry
MedicinePsychiatryMental Health
2002English

An Episode Level Evaluation of the Treatment Journey of Patients With Major Depressive Disorder and Treatment-Resistant Depression

PLoS ONE
Multidisciplinary
2019English

Epigenetics and Major Depression Disorder

Medicina fluminensis
2017English

Preventing Recurrent Depression: Long-Term Treatment for Major Depressive Disorder

The Primary Care Companion to The Journal of Clinical Psychiatry
2007English

Clinically Significant Adverse Events After Major ABO Mismatch BMT

Bone Marrow Transplantation
TransplantationHematology
2015English

Economic Burden of Treatment-Resistant Depression Among Patients Hospitalized for Major Depressive Disorder in the United States

Psychiatric Research and Clinical Practice
2019English

The Burden of Treatment Change in Major Depressive Disorder: Comparison of Switch Versus Non-Switch Patients in the Perform Study

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2013English

Alterations in the Levels of Growth Factors in Adolescents With Major Depressive Disorder: A Longitudinal Study During the Treatment With Fluoxetine

Mediators of Inflammation
ImmunologyCell Biology
2019English

The Incidence of Clinically Significant Venous Thromboembolism in an Asian Population After Major Hepatobiliary and Pancreatic Surgery

International Journal of Hepatobiliary and Pancreatic Diseases
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy